Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2013; 19(1): 72-77
Published online Jan 7, 2013. doi: 10.3748/wjg.v19.i1.72
Published online Jan 7, 2013. doi: 10.3748/wjg.v19.i1.72
Group A | Group B | Group C | P value | |
Number of patients | 25 | 54 | 107 | |
Age (yr) | 0.08 | |||
Median | 64 | 66 | 68 | |
Range | 47-81 | 35-84 | 24-89 | |
Gender | 0.20 | |||
Male | 11 (44) | 28 (52) | 66 (62) | |
Female | 14 (56) | 26 (48) | 41 (38) | |
ECOG performance score | 0.12 | |||
0 | 10 (40) | 13 (24) | 46 (43) | |
1 | 12 (48) | 37 (69) | 50 (47) | |
2-3 | 3 (12) | 4 (7) | 11 (10) | |
Primary biliary site | 0.47 | |||
Gallbladder | 14 (56) | 22 (41) | 46 (43) | |
Intra-hepatic bile duct | 5 (20) | 21 (39) | 40 (37) | |
Extra-hepatic bile duct | 6 (24) | 9 (16) | 20 (19) | |
Ampulla of Vater | 0 (0) | 2 (4) | 1 (1) | |
Disease status | 0.76 | |||
Locally advanced | 6 (24) | 15 (28) | 24 (22) | |
Metastatic | 19 (76) | 39 (72) | 83 (78) |
- Citation: Sasaki T, Isayama H, Nakai Y, Takahara N, Sasahira N, Kogure H, Mizuno S, Yagioka H, Ito Y, Yamamoto N, Hirano K, Toda N, Tada M, Omata M, Koike K. Improvement of prognosis for unresectable biliary tract cancer. World J Gastroenterol 2013; 19(1): 72-77
- URL: https://www.wjgnet.com/1007-9327/full/v19/i1/72.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i1.72